LL-37 5mg

LL-37 is a synthetic cationic alpha-helical research compound based on the C-terminal region of human cathelicidin (hCAP18). It is studied in laboratory settings for its molecular characteristics, membrane interactions, and associated cellular signaling pathways.

Key Research Areas:

• Membrane Interaction Research — Laboratory investigation of LL-37 interactions with membrane structures and associated molecular processes.
• Cellular Signaling Research — Investigation of cellular signaling pathways associated with LL-37.
• TLR Signaling Research — Laboratory characterization of Toll-like receptor-associated molecular signaling.
• NF-κB Pathway Research — Investigation of NF-κB-associated signaling and related molecular processes.
• Molecular Interaction Research — Laboratory characterization of LL-37 and its interactions with molecular and cellular systems.

Product Specifications:

• Cationic alpha-helical research compound
• 37-amino-acid sequence
• Based on the C-terminal region of human cathelicidin (hCAP18)
• Supplied as lyophilized powder
• Batch-specific purity and identity information available via applicable COA
• Store under appropriate controlled laboratory conditions and protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, administration, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic.